سعر انجيوبلوك مونو 75مجم 21 قرص 2025

Irbesartan 75 mg film-coated tablets (angiotensin II receptor blocker), pack of 21 tablets (3 strips), marketed in Egypt by Global Napi / Global Advanced Pharmaceuticals.

• Treatment of hypertension to lower blood pressurePopulation: AdultsDailyMed (U.S. National Library of Medicine)
• Diabetic nephropathy with elevated serum creatinine and proteinuria (>300 mg/day) in patients with type 2 diabetes and hypertensionPopulation: AdultsDailyMed (U.S. National Library of Medicine)

• Adverse reactions more frequent than placebo in hypertension trials: fatigue (4% vs 3%), diarrhea (3% vs 2%), dyspepsia/heartburn (2% vs 1%).International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Hypersensitivity to irbesartan or any component.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Co-administration with aliskiren in patients with diabetes.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Fetal toxicity (boxed warning).International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Symptomatic hypotension may occur in volume- or salt-depleted patients; correct depletion or start at a lower dose.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Changes in renal function, including acute renal failure, may occur in susceptible patients.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Potassium-sparing diuretics, potassium supplements, potassium-containing salt substitutesMay increase serum potassium; monitor.DailyMed (U.S. National Library of Medicine)
• LithiumIncreases in serum lithium and lithium toxicity reported; monitor lithium levels.DailyMed (U.S. National Library of Medicine)
• NSAIDs including selective COX-2 inhibitorsMay deteriorate renal function in elderly, volume-depleted or renally impaired patients and attenuate the antihypertensive effect.DailyMed (U.S. National Library of Medicine)

• Can cause fetal harm; discontinue as soon as possible when pregnancy is detected (boxed warning).International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Breastfeeding is not recommended during treatment.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Irbesartan: Selectively blocks the binding of angiotensin II to the AT1 receptor, inhibiting its vasoconstrictor and aldosterone-secreting effects.